Phenylpiracetam is a member of the racetam family of nootropics. It is known for its potential cognitive-enhancing effects. Phenylpiracetam is believed to improve cognitive performance by modulating various neurotransmitters and receptors in the brain, including acetylcholine, dopamine, and GABA. It has been reported to enhance memory, focus, concentration, and overall cognitive abilities. Some researchers also claim it may provide physical stamina and reduce fatigue which could possibly boost athletic performance.
It is important to emphasize that Phenylpiracetam hydrazide is not FDA-approved for veterinary or human usage. Buy phenylpiracetam hydrazide powder for research purposes only.
Fonturacetam Phenylpiracetam Hydrazide 98% Product Details
Phenylpiracetam hydrazide, alternatively referred to as fonturacetam hydrazide, is a member of the racetam family. It is a modified version of phenylpiracetam, where the original amide group has been replaced with a hydrazide group. The compound was initially documented by a Russian research group in 1980 during their exploration of chemical compounds with potential anticonvulsant properties.
- CAS Number 77472-70-9
- Molar Mass 218.256 g·mol−1
- Chemical Formula C12H14N2O2
- IUPAC Name (R,S)-2-(2-oxo-4-phenylpyrrolidin-1-yl)acetamide
Key Features of Fonturacetam Phenylpiracetam Hydrazide 98% for Sale
- 98% Purity
- 1g | 2g
- Sold for research purposes only
Potential Benefits of Fonturacetam Phenylpiracetam Hydrazide 98%
Phenylpiracetam, particularly its R-isomer, has demonstrated potential effects in alleviating depressive symptoms in animal studies. The R-isomer, known for its increased potency compared to the S-isomer, is believed to significantly reduce depressive behaviors in rats during a forced-swim test. This suggests its potential as an antidepressant agent. [R]
Moreover, in a separate study involving participants experiencing cognitive deterioration, a daily dosage of 200 mg of phenylpiracetam was administered. The results showed a reduction in depressive symptoms among the research subjects. This indicates that phenylpiracetam may have a positive impact on the mood and emotional well-being of participants with cognitive decline. [R]
Mood and Memory Formation
Phenylpiracetam is thought to have the ability to increase the density of various receptors in the brain, including those for acetylcholine (ACh), NMDA, GABA, and dopamine. This increase in receptor density leads to an augmentation of available binding sites for neurotransmitters involved in vital processes such as memory formation, cognition, sleep regulation, and mood modulation. By facilitating neurotransmitter interactions, Phenylpiracetam potentially enhances cognition and emotional aspects of brain function. [R]
In a study conducted in Moscow, a cohort of 400 test subjects that demonstrate symptoms similar to ischemic stroke, the most prevalent type of stroke characterized by blood vessel blockage in the brain, was utilized. Among the clinical participants, half were administered a daily dosage of 400 mg of Phenylpiracetam over the course of one year, while the remaining participants received a placebo. The research findings revealed a noteworthy improvement in cognitive function within the group receiving Phenylpiracetam, indicating a significant restoration of cognitive abilities compared to the control group. [R]
Reaction and Alertness Research
Extensive research has indicated that Phenylpiracetam exhibits notable effects on two crucial types of receptors in the brain: NMDA (N-Methyl-D-Aspartate) and Nicotinic Acetylcholine Receptors. These receptor systems are believed to play pivotal roles in reflexes and reaction times. [R]
Phenylpiracetam has been shown to activate and enhance the functioning of NMDA receptors. These receptors are involved in various cognitive processes, including learning, memory, and synaptic plasticity. By modulating NMDA receptor activity, Phenylpiracetam may contribute to improved cognitive functions, such as enhanced learning abilities and information processing. [R]
Additionally, Phenylpiracetam has been found to impact Nicotinic Acetylcholine Receptors. These receptors are involved in cholinergic neurotransmission, which is crucial for attention, focus, and memory. By increasing the activation and density of these receptors, Phenylpiracetam may promote enhanced cognitive performance and attentional processes. [R]
The activation and upregulation of NMDA and Nicotinic Acetylcholine Receptors in response to Phenylpiracetam may contribute to improved reflexes, reaction times, and cognitive functions. [R]
Phenylpiracetam has been the subject of clinical studies investigating its impact on brain wave activity, particularly in relation to Alpha and Beta waves. While the exact mechanism of action remains unclear, it has been observed to possess an “anti-convulsive” effect within the brain. Findings from a clinical trial indicated that Phenylpiracetam demonstrated a reduction in seizure frequency and an improvement in cognitive function, even in the absence of epileptiform EEG abnormalities. [R]
The augmented density of neuroreceptors is believed to contribute to the stimulant-like effects observed with Phenylpiracetam. Comparable to substances like Ritalin or Adderall, this nootropic compound enhances the efficiency of dopamine in the brain, leading to heightened alertness, improved decision-making ability, and enhanced cognition. By modulating dopamine pathways, Phenylpiracetam has the potential to positively impact various cognitive functions and promote mental clarity. [R]
How It Works
Fonturacetam hydrazide, also known as phenylpiracetam hydrazide, is a racetam that is a phenylpiracetam derivative in which the amide group is replaced with a hydrazide group.
Phenylpiracetam has been shown to elevate the density of important receptors in the brain, including acetylcholine (ACh), NMDA, GABA, and dopamine receptors. As a result, the overall number of receptors increases, thereby providing more binding sites for neurotransmitters involved in regulating mood, cognition, memory, and sleep. This increased availability of binding sites enables enhanced neurotransmitter interactions, potentially leading to improved cognitive abilities, better memory function, balanced mood, and optimize sleep patterns.
When researching the use of Fonturacetam Phenylpiracetam Hydrazide 98%, it is essential to take certain precautions. Here are some precautions to keep in mind:
Observe best practices for studying research chemicals: Studying research chemicals requires a responsible and informed approach to ensure safety and meaningful scientific exploration. Research chemicals, also known as designer drugs or experimental compounds, are substances synthesized for scientific investigation or exploration of their properties.
Follow recommended dosage: Adhere to the recommended dosage instructions outlined on the product label. Avoid exceeding the suggested dose to minimize the risk of potential adverse effects among test subjects.
Safety and Side Effects
Phenylpiracetam, similar to other racetam compounds, has been associated with the potential side effect of headaches in some participants. This occurrence highlights the importance of monitoring participants’ reactions and adjusting dosages accordingly.
Another side effect that may arise from the stimulating properties of phenylpiracetam is insomnia, particularly when the research compound is taken later in the day. The heightened alertness and wakefulness induced by phenylpiracetam can interfere with the quality of sleep obtained, potentially leading to difficulties in falling asleep or maintaining restful sleep.
In addition to headaches and insomnia, another side effect to consider is irritability. Phenylpiracetam, similar to piracetam, may occasionally cause a sensation akin to “sensory overload,” resulting in irritability in some users. It is advisable to adjust the dosage of phenylpiracetam to potentially alleviate these side effects. However, in certain instances, discontinuing the use of the substance may be necessary if the side effects persist or significantly impact overall well-being.
In conclusion, Phenylpiracetam, a member of the racetam compound family derived from phenylpiracetam, has shown potent potential as a cognitive enhancer. Phenylpiracetam hydrazide research conducted by a Russian research group has indicated that the hydrazide group, which replaces the amide group in phenylpiracetam hydrazide powder, plays a role in significantly improving cognitive function. Numerous studies on reflex and reaction time have demonstrated its ability to enhance cognitive performance and increase mental sharpness.
Furthermore, Phenylpiracetam has been found to influence significant brain chemicals such as dopamine, acetylcholine (ACh), NMDA, and GABA receptors. By increasing the density of these receptors, Phenylpiracetam optimizes neurotransmitter binding, resulting in improved memory, enhanced cognitive ability, and balanced mood. Additionally, it has been suggested that Phenylpiracetam may enhance blood flow, potentially benefiting participants whose cognitive function is impacted by restricted blood flow, such as those with a blood clot blocking blood arteries.
The alleged cognitive benefits of Phenylpiracetam extend beyond memory and cognitive ability. Research subjects have reported increased physical endurance, suggesting that Phenylpiracetam may have performance-enhancing effects in addition to its cognitive benefits.
In summary, Phenylpiracetam has emerged as a promising cognitive enhancer within the racetam compound family. Its ability to influence key brain chemicals, enhance cognitive performance, and potentially improve blood flow makes it an intriguing substance for individuals seeking to optimize their cognitive abilities, counteract cognitive deterioration, and positively influence mood. Further research on Phenylpiracetam hydrazide, fonturacetam hydrazide, and related compounds may shed more light on their specific benefits and mechanisms of action.
Please take note of the scientific applications of this product and carefully read our Terms and Conditions before purchasing RCD.bio. By completing your order and submitting payment, you agree to abide by the Terms and Conditions of our company. Please be aware that the product packaging may differ slightly from the images displayed on our website.
If for any reason you are not completely satisfied with the product you receive, please contact us at [email protected]. Our team is dedicated to ensuring satisfaction among our customers.
PLEASE NOTE: Consistent with its aim to be the best research compound supplier, all products offered by RCD.bio are strictly intended for laboratory and research purposes only. They are not intended for use on animals or humans.